Author Question: In a repeated treatment design, subjects' responses are measured a. on several experimental ... (Read 97 times)

deesands

  • Hero Member
  • *****
  • Posts: 514
In a repeated treatment design, subjects' responses are measured
 
  a. on several experimental variables
  b. before and after repeated treatments
  c. once before and several times after treatment is administered
  d. only after treatment has been repeated several times

Question 2

If X = experimental treatment and O = pretest or posttest observation, then O X O X O X O represents the _____ design.
 
  a. repeated treatment
  b. mixed factorial
  c. regression discontinuity
  d. interrupted time series



ergserg

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

b

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library